Humana (HUM) shares were down about 22% in Wednesday's premarket activity after it disclosed in a regulatory filing that the number of members enrolled for 2025 in its Medicare Advantage Plans rated four stars or higher fell to 25%, or 1.6 million, from 94% in 2024.
The company said a driver of these results was one of its contracts with 45% of its Medicare Advantage members decreasing to a 3.5-star rating from a 4.5 star rating.
The company said its 2025 stars results are not expected to impact the company's financial results or outlook for 2024 or 2025. It is attempting to challenge some of the numbers that led to the decline, the company added.
Humana said in the regulatory filing that it is "disappointed with its performance and has initiatives underway focused on improving its operating discipline and returning to an industry-leading stars position as quickly as possible."
Price: 217.99, Change: -61.46, Percent Change: -21.99
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。